Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp

Cephalalgia

Volumn 30, Issue 8, 2010, Pages 1000-1006

  Cutrer, F M ^a   Sandroni, P ^a   Wendelschafer Crabb, G ^b  

^a Mayo Clinic College of Medicine   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CALCITONIN GENE RELATED PEPTIDE; SUBSTANCE P; MUSCLE RELAXANT AGENT;

ALOPECIA; ARTICLE; CASE REPORT; CONTROLLED STUDY; EPIDERMAL NERVE FIBER; FEMALE; HAIR FOLLICLE; HAIR GROWTH; HEADACHE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAST CELL DEGRANULATION; NERVE FIBER; NERVE PLEXUS; PUNCH BIOPSY; SCALP; SKIN NERVE; SUBEPIDERMAL NEURAL PLEXUS; CONFOCAL MICROSCOPY; DEGRANULATION; DRUG EFFECT; INNERVATION; MAST CELL; METABOLISM; NERVE CELL; PATHOLOGY;

ALOPECIA; BOTULINUM TOXIN TYPE A; CALCITONIN GENE-RELATED PEPTIDE; CELL DEGRANULATION; FEMALE; HAIR FOLLICLE; HEADACHE; HUMANS; IMMUNOHISTOCHEMISTRY; MAST CELLS; MICROSCOPY, CONFOCAL; NEUROMUSCULAR AGENTS; NEURONS; SCALP; SUBSTANCE P;

EID: 78349254226     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01987.x     Document Type: Article

References (14)

1. Cutrer FM, Pittlekow MR. Cephalalgic alopecia areata: a syndrome of neuralgiform head pain and hair loss responsive to Botulinum a toxin injection. Cephalalgia 2006; 26: 492.
2. Winkelmann RK. Cutaneous sensory nerves. Sem Dermatol 1988; 7: 236-68. (Pubitemid 19101717)
3. Cotsarelis F, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implica-tions for follicular stem cells, hair cycle, and skin carci-nogenesis. Cell 1990; 61: 1329-37.
4. Bevin S, Szolscanyi J. Sensory neuron-specific actions of capsaicin: mechanism and applications. TIPS 1990; 11: 330-3.
5. Paus R, Heinzelmann T, Schultz K-D, Furkert J, Fechner K, Czarnetzki BM. Hair growth induction by Substance P. Lab Invest 1994; 71: 134-40. (Pubitemid 24246030)
6. Dimitriadou V, Buzzi MG, Theoharides TC, Moskowitz MA. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 1992; 48: 187-203.
7. Nong YH, Titus RG, Ribeiro JM, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage func-tion. J Immunol 1989; 143: 45-9. (Pubitemid 19174197)
8. Wang F, Millet I, Bottomly K, Vignery A. Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes. J Biol Chem 1992; 267: 21052-7.
9. Kennedy WR, Wendelschafer-Crabb G, Polydefkis M, McArthur J. Pathology and quantitation of cutaneous nerves. In: Dyck PJ, Thomas PK (eds) Peripheral neuropa-thy. 4th edn. Philadelphia, PA: Saunders, 2005, p.869-96.
10. Siebenhaar F, Sharov AA, Peters EM, Sharova TY, Syska W, Mardaryev AN, et al. Substance P as an immu-nomodulatory neuropeptide in a mouse model for auto-immune hair loss (alopecia areata). J Invest Dermatol 2007; 127: 1489-97. (Pubitemid 46766534)
11. Peters EM, Liotiri S, Bodo E, Hagen E, Biro T, Arck PC, Paus R. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. AmJPathol2007; 171: 1872-86.
12. Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 2007; 130: 166-76. (Pubitemid 46843463)
13. Durham PL, Cady R, Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 2004; 44: 35-43. (Pubitemid 38116660)
14. Pareja JA, Cuadrado ML, Feranadez-de-las Penas C, Neito C, Sols M, Pinedo F. Nummular headache with trophic changes inside the painful area. Cephalagia 2008; 28: 186-90.